DoD Gulf War Illness, Patient-Provider and Health Communications Award | W81XWH 19 GWIRP PPHCA

Opportunity Information: Apply for W81XWH 19 GWIRP PPHCA

The DoD Gulf War Illness, Patient-Provider and Health Communications Award (FY19 GWIRP PPHCA; W81XWH-19-GWIRP-PPHCA) is a Department of Defense funding opportunity designed to improve how Gulf War Illness (GWI) research and clinical knowledge is communicated to the people who need it most. Instead of focusing on generating new biomedical findings, this award centers on building practical tools, processes, and dissemination approaches that increase awareness and understanding of evidence-based GWI research across real-world communities. The intended audiences include Gulf War Veterans living with GWI, their caregivers and advocates, healthcare providers who treat or advise these Veterans, and public health professionals whose work touches Veteran health.

A key theme of the opportunity is translating the “state of the science” into communication strategies that can be used in near-term, high-impact ways. Proposed projects are expected to help diverse audiences better understand current research findings and clinical insights, and to make those findings easier to discuss and apply in everyday settings such as clinic visits, care planning, self-management, and caregiver support. Importantly, the solicitation emphasizes that strategies can draw from GWI findings at any phase of the research pipeline, meaning applicants can focus on communicating emerging knowledge as well as more established evidence, as long as the effort is grounded in credible, research-backed information.

The award’s definition of impact is strongly tied to quality of life. The Department of Defense is looking for projects that can quickly improve how Veterans, caregivers, and clinicians talk about GWI, including its symptoms, potential treatments, and approaches to disease management. Successful applications would generally show a clear path to adoption and use, such as implementing communication products through clinical networks, Veteran-serving organizations, training pathways, public health channels, or scalable platforms. Another explicit goal is to reduce stigma and remove barriers that can block effective care and understanding. Applicants are encouraged to develop strategies that address professional, personal, or institutional misconceptions about GWI, and that motivate people to stay informed as research evolves.

A defining requirement of this award is meaningful Gulf War Veteran involvement. Every application must include at least one Gulf War Veteran who has GWI, and that Veteran must be integrated throughout the project, not added as a token advisor. The Veteran participant is expected to contribute to shaping the project idea, helping design the approach, supporting oversight, and participating in evaluation so that the end products genuinely reflect Veteran needs and realities. The opportunity stresses that engagement should be ongoing and embedded in the project’s working processes rather than limited to occasional meetings or ceremonial roles.

The solicitation also sets boundaries to protect the independence and authenticity of the Veteran’s contribution. The involved Gulf War Veteran cannot be an employee of any organization participating in the application, though they may be paid as a consultant or collaborator. Their role should focus on providing objective, experience-informed input on the communication strategy and deliverables, with attention to whether the project is likely to create substantive benefits for people living with GWI. The Veteran is expected to bring strong familiarity with GWI symptoms and impacts, current challenges in clinical care, and the existing GWI research landscape so they can contribute at a high level to both planning and execution.

In terms of what applicants might build, the award is open to a range of health communication and dissemination mechanisms. This includes media-based strategies, technical platforms, organizational systems, and other venues that can spread research findings effectively and responsibly. The aim is not simply to publish information, but to encourage real uptake of evidence-based approaches to understanding, managing, and treating GWI. Projects should be designed with the practical realities of clinical workflows, patient-provider conversations, caregiver needs, and public health messaging in mind.

Administratively, this opportunity was released by the Department of Defense, Department of the Army, through USAMRAA, under CFDA 12.420, within the Science and Technology and other Research and Development activity category. It was offered as a discretionary program using grant and cooperative agreement funding instruments, with eligibility listed as unrestricted (open to any type of entity, subject to any additional eligibility language in the full announcement). The posting date was May 16, 2019, with an original closing date of October 3, 2019. The notice indicated one expected award, and the award ceiling was listed as 0 in the source data, which typically signals that the cap may have been defined elsewhere in the full solicitation or structured in a way not captured by that single field.

Overall, this award is best understood as an implementation and impact-focused funding mechanism. It prioritizes high-quality, evidence-based communication that can quickly improve understanding, reduce stigma, and strengthen patient-provider dialogue around Gulf War Illness, while requiring that Veterans with GWI help guide the project from start to finish so the outputs stay grounded in lived experience and real-world usefulness.

• The Department of Defense, Dept. of the Army -- USAMRAA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoD Gulf War Illness, Patient-Provider and Health Communications Award" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
• This funding opportunity was created on May 16, 2019.
• Applicants must submit their applications by Oct 03, 2019. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• The number of recipients for this funding is limited to 1 candidate(s).
• Eligible applicants include: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled Additional Information on Eligibility.

Apply for W81XWH 19 GWIRP PPHCA

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: